Surya Biru Murni Acetylene Tbk PT Net Assets

Latest as of June 2026: Rp241.06 Billion IDR ≈ $14.13 Million USD

Surya Biru Murni Acetylene Tbk PT net assets. Based on the latest financial reports, Surya Biru Murni Acetylene Tbk PT (SBMA) has net assets worth Rp241.06 Billion IDR (≈ $14.13 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp298.43 Billion ≈ $17.49 Million USD) and total liabilities (Rp57.37 Billion ≈ $3.36 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Surya Biru Murni Acetylene Tbk PT (SBMA) equity growth momentum to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric Value
Current Net Assets Rp241.06 Billion
% of Total Assets 80.78%
Annual Growth Rate 18.63%
5-Year Change 16.46%
10-Year Change N/A
Growth Volatility 32.02

Net Assets of Surya Biru Murni Acetylene Tbk PT (2018–2025)

Net assets of Surya Biru Murni Acetylene Tbk PT from 2018 to 2025. This chart illustrates how Surya Biru Murni Acetylene Tbk PT's net assets have evolved over time, based on quarterly financial data. See SBMA equity financing ratio to measure how much of total assets are equity-financed.

Annual Net Assets for Surya Biru Murni Acetylene Tbk PT (2018–2025)

The table below shows the annual net assets of Surya Biru Murni Acetylene Tbk PT from 2018 to 2025. For live market cap and overall valuation, see Surya Biru Murni Acetylene Tbk PT stock valuation.

Year Net Assets Change
2025-12-31 Rp239.08 Billion
≈ $14.01 Million
+4.91%
2024-12-31 Rp227.90 Billion
≈ $13.35 Million
+5.78%
2023-12-31 Rp215.45 Billion
≈ $12.62 Million
+2.07%
2022-12-31 Rp211.07 Billion
≈ $12.37 Million
+2.82%
2021-12-31 Rp205.29 Billion
≈ $12.03 Million
+36.88%
2020-12-31 Rp149.98 Billion
≈ $8.79 Million
+95.38%
2019-12-31 Rp76.76 Billion
≈ $4.50 Million
+6.20%
2018-12-31 Rp72.28 Billion
≈ $4.24 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Surya Biru Murni Acetylene Tbk PT's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 32.1% over the analyzed period, potentially due to dividend distributions or operating losses.

Surya Biru Murni Acetylene Tbk PT Net Assets Breakdown (December 2025)

Surya Biru Murni Acetylene Tbk PT net assets breakdown by equity component as of December 2025.

Component Amount Percentage
Retained Earnings Rp37.92 Billion 15.86%
Common Stock Rp92.99 Billion 38.90%
Other Comprehensive Income Rp78.78 Billion 32.95%
Other Components Rp29.39 Billion 12.29%
Total Equity Rp239.08 Billion 100.00%

Surya Biru Murni Acetylene Tbk PT Competitors by Market Cap

The table below lists competitors of Surya Biru Murni Acetylene Tbk PT ranked by their market capitalization.

Company Market Cap
Clearmind Medicine Inc. Common Shares
NASDAQ:CMND
$5.61 Million
Boqii Holding Limited
NYSE:BQ
$5.61 Million
Alpha Compute Corp
NASDAQ:ALP
$5.62 Million
Middle Island Resources Ltd
AU:MDI
$5.62 Million
Premier Products Public Company Limited
BK:PPP
$5.61 Million
City Steel Public Company Limited
BK:CITY
$5.61 Million
SMIS Corporation Bhd
KLSE:7132
$5.61 Million
MKDWELL Tech Inc. Ordinary Share
NASDAQ:MKDW
$5.61 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Surya Biru Murni Acetylene Tbk PT's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 227,898,084,000 to 239,082,277,000, a change of 11,184,193,000 (4.9%).
  • Net income of 11,792,190,000 contributed positively to equity growth.
  • Dividend payments of 3,719,705,000 reduced retained earnings.
  • Other comprehensive income increased equity by 4,111,707,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income Rp11.79 Billion +4.93%
Dividends Paid Rp3.72 Billion -1.56%
Other Comprehensive Income Rp4.11 Billion +1.72%
Other Changes Rp-1000.00 Million -0.42%
Total Change Rp- 4.91%

Book Value vs Market Value Analysis

This analysis compares Surya Biru Murni Acetylene Tbk PT's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.40x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 1.46x to 0.40x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2018-12-31 Rp70.78 Rp103.00 x
2019-12-31 Rp75.17 Rp103.00 x
2020-12-31 Rp146.86 Rp103.00 x
2021-12-31 Rp221.13 Rp103.00 x
2022-12-31 Rp227.13 Rp103.00 x
2023-12-31 Rp231.79 Rp103.00 x
2024-12-31 Rp245.19 Rp103.00 x
2025-12-31 Rp257.10 Rp103.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Surya Biru Murni Acetylene Tbk PT utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 4.93%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 8.60%
  • • Asset Turnover: 0.47x
  • • Equity Multiplier: 1.21x
  • Recent ROE (4.93%) is above the historical average (4.43%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2018 7.19% 7.80% 0.54x 1.71x Rp-2.03 Billion
2019 6.02% 6.42% 0.57x 1.66x Rp-3.06 Billion
2020 3.54% 7.14% 0.38x 1.30x Rp-9.69 Billion
2021 3.61% 8.40% 0.35x 1.22x Rp-13.12 Billion
2022 2.12% 4.33% 0.38x 1.28x Rp-16.62 Billion
2023 2.20% 4.17% 0.41x 1.28x Rp-16.81 Billion
2024 5.86% 10.14% 0.45x 1.27x Rp-9.43 Billion
2025 4.93% 8.60% 0.47x 1.21x Rp-12.12 Billion

Industry Comparison

This section compares Surya Biru Murni Acetylene Tbk PT's net assets metrics with peer companies in the Chemicals industry.

Industry Context

  • Industry: Chemicals
  • Average net assets among peers: $89,899,190,363
  • Average return on equity (ROE) among peers: 2.81%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Surya Biru Murni Acetylene Tbk PT (SBMA) Rp241.06 Billion 7.19% 0.24x $5.61 Million
Polychem Indonesia Tbk (ADMG) $-1.53 Trillion 0.00% 0.00x $44.44 Million
Aneka Gas Industri Tbk PT (AGII) $218.63 Billion 0.00% 2.03x $600.18 Million
Bintang Mitra Semestaraya Tbk (BMSR) $147.82 Billion 3.76% 3.04x $18.61 Million
Barito Pacific Tbk (BRPT) $2.95 Billion 4.79% 1.60x $4.67 Billion
Surya Esa Perkasa Tbk (ESSA) $183.09 Million 2.86% 0.52x $492.60 Million
Eterindo Wahanatama Tbk (ETWA) $392.31 Billion 0.00% 0.12x $19.15 Million
Madusari Murni Indah Tbk PT (MOLI) $1.16 Trillion 6.68% 0.61x $49.80 Million
Indo Acidatama Tbk (SRSN) $415.51 Billion 4.26% 0.57x $34.57 Million
Unggul Indah Cahaya Tbk (UNIC) $126.39 Million 2.92% 1.25x $313.34 Million

About Surya Biru Murni Acetylene Tbk PT

JK:SBMA Indonesia Chemicals
Market Cap
$5.61 Million
Rp95.78 Billion IDR
Market Cap Rank
#28261 Global
#682 in Indonesia
Share Price
Rp103.00
Change (1 day)
-2.83%
52-Week Range
Rp93.00 - Rp150.00
All Time High
Rp501.27
About

PT Surya Biru Murni Acetylene Tbk produces chemical industrial gases in Indonesia. It offers acetylene, oxygen, and nitrogen, as well as argon, carbon dioxide, helium, and mixed gases; and new air separation plant, cylinder maintenance, gas equipment and installation, transport and distribution, gas chromatograph, and gases for laboratory and testing applications. PT Surya Biru Murni Acetylene Tb… Read more